Exploring caregiver experiences with the altitudes digital mental health program: A thematic analysis

• by Kelsey Ludwig, Elizabeth Fraser, David Penn, Bryan Stiles, Hanna Campbell, Heidi Dittus, Rathisree Seenivasan, Jeongwoo Lee, Mario Alvarez-Jimenez, John Gleeson

• June 6, 2026

Enrollment in Integrated Special Needs Plans Among Dually Eligible Beneficiaries With Serious Mental Illness

• by Emma E. McGinty, Gail L. Daumit, Manyao Zhang, Yongkang Zhang

• June 1, 2026

Retraction: Impaired potentiation of theta oscillations during a visual cortical plasticity paradigm in individuals with schizophrenia

• May 6, 2026

FDA Updates Lumateperone Label With Relapse-Prevention Data

Label update incorporates randomized withdrawal trial findings showing delayed time to relapse and consistent safety profile in schizophrenia

• by Kathryn Wighton

• April 29, 2026

• 2 min